AthemBio
PrivateLast Round
Grant
Aug 15, 2024
Total Funding Raised
$260,943
Company Overview
AthemBio is a biotechnology company that develops automated, single-use bioprocessing platforms designed to reduce manufacturing complexity and costs for biologics and advanced therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Smart Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales, Data as a Service, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AthemBio Comparables
Compare AthemBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sartorius Aktiengesellschaft | 76% | |
| Danaher Corporation | 73% | |
| Thermo Fisher Scientific Inc. | 73% | |
AthemBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 15, 2024 | ||||
| Accelerator | Aug 10, 2022 | ||||
| Grant | Feb 9, 2021 |
AthemBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Public Health Emergency Medical Countermeasures Enterprise | Accelerator |
| First Flight Venture Center | Accelerator |
| National Science Foundation | Grant |
AthemBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AthemBio's valuation, stock price, and market status.